# Cardiac resynchronization device

Technology · id `cardio:cardiac-resynchronization-device` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: CRT device; CRT-P; CRT-D; Biventricular pacemaker

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A cardiac resynchronization device is a type of artificial pacemaker with leads placed at several sites in the heart. The MeSH scope note says such devices treat conduction disturbances that interfere with the timing of contraction of the ventricles, and that they may or may not include defibrillating electrodes. FDA lists three types as class 3 devices: CRT pacemakers (product code NKE), CRT defibrillators (NIK) and leadless CRT (SEG). The classification definitions name patients who have moderate to severe heart failure. One 2005 FDA approval supplement for a family of CRT pacemakers (P030035, supplement S003, approved 29 April 2005) states indications in heart failure and is quoted as an example; the original approval, other supplements and current labeling were not read. This page records no study of benefit or harm.

## Technical summary

MeSH descriptor D058409 (Cardiac Resynchronization Therapy Devices) is an exact match; its broader descriptor is D010138 (Pacemaker, Artificial), the exact match of the pacemaker page. FDA product codes NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)), NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)) and SEG (Leadless Cardiac Resynchronization Therapy (Crt)), each class 3 in the openFDA classification records read 2026-11-18, are broad matches: each names one type of device. The approval facts are for one device family, the Frontier and Frontier II pacemakers (premarket approval P030035; supplement S003, decision 2005-04-29, product code NKE). The procedure has its own page.

## Claims, with the population each applies to

## Context: Cardiac resynchronization devices as classified by the US FDA under product codes NKE, NIK and SEG

Recipient: No clinical recipient; Population: Not applicable: the classification records describe device types, not a patient group, although the NKE and NIK definitions name patients who have moderate to severe heart failure.; Care setting: Not stated in the classification records; Geography: United States (FDA device classification record); Life stage: Not applicable; Follow-up: Not applicable (regulatory classification)

### The openFDA device classification names three product codes for cardiac resynchronization devices, each in class 3: NKE, a pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P); NIK, an automatic implantable cardioverter defibrillator with cardiac resynchronization (CRT-D); and SEG, leadless cardiac resynchronization therapy. The NKE definition says the devices are indicated for patients who have moderate to severe heart failure and use an additional lead to provide synchronized pacing. The NIK definition says the devices will be indicated for patients needing an ICD who also have moderate to severe heart failure and are indicated for cardiac resynchronization therapy. The SEG definition says the therapy is intended to deliver CRT using a leadless left ventricular implant.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: No clinical recipient; Population: Not applicable: the classification records describe device types, not a patient group, although the NKE and NIK definitions name patients who have moderate to severe heart failure.; Care setting: Not stated in the classification records; Geography: United States (FDA device classification record); Life stage: Not applicable; Follow-up: Not applicable (regulatory classification)
- Limitations: A regulatory classification, not a finding about benefit or safety. The definitions are brief and give no clinical criteria for use. The NIK definition is written in the future tense (will be indicated); it is quoted as FDA wrote it. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Supports: openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NKE>
     Locator: results\[0\].product\_code. Retrieved 2026-11-18T17:25:52Z. Source state: Current. Version fingerprint: 621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd.
     How it applies: Quoted at this locator.
  2. Supports: openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NKE>
     Locator: results\[0\].device\_name. Retrieved 2026-11-18T17:25:52Z. Source state: Current. Version fingerprint: 621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd.
     How it applies: Quoted at this locator.
  3. Supports: openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NKE>
     Locator: results\[0\].device\_class. Retrieved 2026-11-18T17:25:52Z. Source state: Current. Version fingerprint: 621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd.
     How it applies: Quoted at this locator.
  4. Supports: openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NIK>
     Locator: results\[0\].product\_code. Retrieved 2026-11-18T17:25:54Z. Source state: Current. Version fingerprint: c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458.
     How it applies: Quoted at this locator.
  5. Supports: openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NIK>
     Locator: results\[0\].device\_name. Retrieved 2026-11-18T17:25:54Z. Source state: Current. Version fingerprint: c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458.
     How it applies: Quoted at this locator.
  6. Supports: openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NIK>
     Locator: results\[0\].device\_class. Retrieved 2026-11-18T17:25:54Z. Source state: Current. Version fingerprint: c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458.
     How it applies: Quoted at this locator.
  7. Supports: openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:SEG>
     Locator: results\[0\].product\_code. Retrieved 2026-11-18T17:25:55Z. Source state: Current. Version fingerprint: 25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae.
     How it applies: Quoted at this locator.
  8. Supports: openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:SEG>
     Locator: results\[0\].device\_name. Retrieved 2026-11-18T17:25:55Z. Source state: Current. Version fingerprint: 25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae.
     How it applies: Quoted at this locator.
  9. Supports: openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:SEG>
     Locator: results\[0\].device\_class. Retrieved 2026-11-18T17:25:55Z. Source state: Current. Version fingerprint: 25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae.
     How it applies: Quoted at this locator.
  10. Supports: openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NKE>
     Locator: results\[0\].definition, sentence 1. Retrieved 2026-11-18T17:25:52Z. Source state: Current. Version fingerprint: 621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd.
     How it applies: Quoted at this locator.
  11. Supports: openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NKE>
     Locator: results\[0\].definition, sentence 2. Retrieved 2026-11-18T17:25:52Z. Source state: Current. Version fingerprint: 621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd.
     How it applies: Quoted at this locator.
  12. Supports: openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NIK>
     Locator: results\[0\].definition, fragment 1 of 2. Retrieved 2026-11-18T17:25:54Z. Source state: Current. Version fingerprint: c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458.
     How it applies: Quoted at this locator.
  13. Supports: openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:NIK>
     Locator: results\[0\].definition, fragment 2 of 2. Retrieved 2026-11-18T17:25:54Z. Source state: Current. Version fingerprint: c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458.
     How it applies: Quoted at this locator.
  14. Supports: openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT)) (Regulator, edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09.) <https://api.fda.gov/device/classification.json?search=product_code:SEG>
     Locator: results\[0\].definition. Retrieved 2026-11-18T17:25:55Z. Source state: Current. Version fingerprint: 25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae.
     How it applies: Quoted at this locator.

## Context: Patients for whom the 2005 US approval order for the Frontier cardiac resynchronization pacemakers states an indication: heart failure

Recipient: Recipient not specified; Population: Patients with heart failure as the order words it: two groups, described in the order's own terms (NYHA class, ejection fraction, QRS duration, AV nodal ablation). The statement read does not name an age group.; Care setting: Implanted cardiac resynchronization pacemaker; Geography: United States (FDA premarket approval supplement record); Life stage: Not stated in the statement read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory statement)

### The openFDA record of premarket approval supplement S003 to P030035 (applicant Abbott Medical, decision APPR, 29 April 2005, product code NKE) is for the Frontier Model 5508L and Frontier II Model 5586 cardiac resynchronization therapy pacemakers. The order says the devices are indicated for maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA class II or III heart failure, and for reducing the symptoms of moderate to severe heart failure (NYHA class III or IV) in patients who remain symptomatic despite stable, optimal medical therapy and have an ejection fraction in the left ventricle of 35% or less and a prolonged QRS duration.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with heart failure as the order words it: two groups, described in the order's own terms (NYHA class, ejection fraction, QRS duration, AV nodal ablation). The statement read does not name an age group.; Care setting: Implanted cardiac resynchronization pacemaker; Geography: United States (FDA premarket approval supplement record); Life stage: Not stated in the statement read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory statement)
- Limitations: This claim covers one supplement (S003, 2005) for one pacemaker family. P030035 has other supplements, and other cardiac resynchronization devices have their own approvals; none of them was read for this page, and current labeling was not read. An FDA approval is a decision about a device, not a finding about how well it works. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].pma\_number. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  2. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].supplement\_number. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  3. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].applicant. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  4. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].trade\_name. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  5. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].decision\_date. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  6. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].decision\_code. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  7. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].product\_code. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  8. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].ao\_statement, fragment 1 of 5. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  9. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].ao\_statement, fragment 2 of 5. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  10. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].ao\_statement, fragment 3 of 5. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  11. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].ao\_statement, fragment 4 of 5. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.
  12. Supports: FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record) (Regulator, edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA.) <https://api.fda.gov/device/pma.json?search=pma_number:P030035>
     Locator: results\[0\].ao\_statement, fragment 5 of 5. Retrieved 2026-11-18T17:26:01Z. Source state: Current. Version fingerprint: 16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c.
     How it applies: Quoted at this locator.

## Connected pages

- Filed under pacemakers: Pacemaker (`cardio:pacemaker`)
- FDA classification records describe these devices for patients with moderate to severe heart failure: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-crt-classification` and its context]
- A 2005 US approval supplement for one pacemaker family states indications in heart failure: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-frontier-crt-pacemakers-indications` and its context]
- Defibrillators are described on their own page: Implantable cardioverter-defibrillator (ICD) (`cardio:implantable-cardioverter-defibrillator`)
- Filed under this front: Devices and monitoring (`cardio:front-devices-and-monitoring`)
- Used by: Cardiac resynchronization therapy (CRT) (`cardio:cardiac-resynchronization-therapy-crt`)

## Provenance

Content hash: 1413918383b24f5b1fd6cac6baf51f5e7a84e7bfa272482cf30a914137658c57
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
